Patent details

EP2129376 Title: Treatment of cancers with acquired resistance to KIT inhibitors

Basic Information

Publication number:
EP2129376
PCT Application Number:
PCT/US/2008/051406
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087278883
PCT Publication Number:
WO/2008/089389
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Treatment of cancers with acquired resistance to KIT inhibitors
French Title of Invention:
Traitement de cancers à résistance acquise aux inhibiteurs KIT
German Title of Invention:
Behandlung von Tumoren mit erworbener Resistenz gegen KIT-Hemmer
SPC Number:

Dates

Filing date:
18/01/2008
Grant date:
24/07/2013
EP Publication Date:
24/07/2013
PCT Publication Date:
24/07/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/12/2009
EP B1 Publication Date:
24/07/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/01/2014
Expiration date:
18/01/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/01/2008
 
 

Name:
Bayer HealthCare LLC
Address:
555 White Plains Road, Tarrytown, NY 10591, United States (US)

Inventor

1

Name:
WILHELM Scott
Address:
United States (US)

2

Name:
GEDRICH Richard W.
Address:
United States (US)

Priority

Priority Number:
885728 P
Priority Date:
19/01/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/44;
Filing date Document type Number of pages